ArticleFrontiers in pharmacology2023
Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis.
Abstract read
In one paragraph
Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Reducing Exposure Before Birth: An Interrupted Time Series Study of Prenatal Exposure to Fetotoxic Medications Under Risk Management Plans in Canada.Clinical pharmacology and therapeutics · 2026Article
- Identifying Pregnancies in Population-Based Data Sources: Development and Application of the ConcePTION Pregnancy Algorithm.Pharmacoepidemiology and drug safety · 2026Article
- Compliance with the European Pregnancy Prevention Programme in Isotretinoin Treatment: Safety Outcomes and Dose-Related Correlations.Journal of clinical medicine · 2025Article
- Latvian Healthcare Professionals' Self-Reported Knowledge, Attitudes, and Behaviors Related to Pregnancy Prevention Program Materials for Valproate-Containing Medicines.Pharmacy (Basel, Switzerland) · 2024Article
- Adverse Pregnancy and Child Outcomes in Oral Retinoid-Exposed Pregnancies: A Nationwide Population-Based Study.Journal of Korean medical science · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
42 authors.
Carlos E DuránJulius Center for Health Sciences and Primary Care, Department of Data Science and Biostatistics, University Medical Center Utrecht, Utrecht, Netherlands.
Judit Riera-ArnauJulius Center for Health Sciences and Primary Care, Department of Data Science and Biostatistics, University Medical Center Utrecht, Utrecht, Netherlands.
Shahab AbtahiDivision of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, Utrecht, Netherlands.
Romin PajouheshniaDivision of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, Utrecht, Netherlands.
Vjola HoxhajJulius Center for Health Sciences and Primary Care, Department of Data Science and Biostatistics, University Medical Center Utrecht, Utrecht, Netherlands.
Magdalena GambaDivision of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, Utrecht, Netherlands.
Ema AlsinaJulius Center for Health Sciences and Primary Care, Department of Data Science and Biostatistics, University Medical Center Utrecht, Utrecht, Netherlands.
Mar Martin-PerezAgencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.
Patricia Garcia-PozaAgencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.
Ana Llorente-GarciaAgencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.
Diana Gonzalez-BermejoAgencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.
Luisa IbánezDepartment of Clinical Pharmacology, Vall Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Mònica SabatéDepartment of Clinical Pharmacology, Vall Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Xavier VidalDepartment of Clinical Pharmacology, Vall Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Elena BallarínDepartment of Clinical Pharmacology, Vall Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Gabriel Sanfélix-GimenoThe Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Health Services Research Unit (FISABIO - HSRU), Valencia, Spain.
Clara Rodríguez-BernalThe Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Health Services Research Unit (FISABIO - HSRU), Valencia, Spain.
Salvador PeiróThe Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Health Services Research Unit (FISABIO - HSRU), Valencia, Spain.
Aníbal García-SempereThe Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Health Services Research Unit (FISABIO - HSRU), Valencia, Spain.
Francisco Sanchez-SaezThe Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Health Services Research Unit (FISABIO - HSRU), Valencia, Spain.
Valentina IentileDepartment of Biomedical and Dental Sciences and Morpho-functional Imaging, University of Messina, Messina, Italy.
Ylenia IngrasciottaSection of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Claudio GuarneriDepartment of Biomedical and Dental Sciences and Morpho-functional Imaging, University of Messina, Messina, Italy.
Matilde TanagliaSection of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Michele TariCaserta Local Health Unit, Caserta, Italy.
Ron HeringsPHARMO Institute, Utrecht, Netherlands.
Eline HoubenPHARMO Institute, Utrecht, Netherlands.
Karin Swart-PolinderPHARMO Institute, Utrecht, Netherlands.
Emily HolthuisPHARMO Institute, Utrecht, Netherlands.
Consuelo HuertaDepartment of Public Health and Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
Rosa GiniAgenzia Regionale di Sanità Della Toscana (ARS), Florence, Italy.
Giuseppe RobertoAgenzia Regionale di Sanità Della Toscana (ARS), Florence, Italy.
Claudia BartoliniAgenzia Regionale di Sanità Della Toscana (ARS), Florence, Italy.
Olga PaolettiAgenzia Regionale di Sanità Della Toscana (ARS), Florence, Italy.
Giorgio LimoncellaAgenzia Regionale di Sanità Della Toscana (ARS), Florence, Italy.
Anna GirardiAgenzia Regionale di Sanità Della Toscana (ARS), Florence, Italy.
Giulia HyeraciAgenzia Regionale di Sanità Della Toscana (ARS), Florence, Italy.
Morten AndersenPharmacovigilance Research Center, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Sarah Brøgger KristiansenPharmacovigilance Research Center, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Christine Erikstrup HallgreenCopenhagen Centre for Regulatory Science, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Olaf KlungelDivision of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, Utrecht, Netherlands.
Miriam SturkenboomJulius Center for Health Sciences and Primary Care, Department of Data Science and Biostatistics, University Medical Center Utrecht, Utrecht, Netherlands.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
acnecontraceptive measuresdermatologic conditionsisotretinoinoral retinoidspregnancy prevention programmerisk minimisation measures
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.